Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma

被引:73
|
作者
Charous, SJ
Stricklin, GP
Nanney, LB
Netterville, JL
Burkey, BB
机构
[1] VANDERBILT UNIV,MED CTR,DEPT OTOLARYNGOL HEAD & NECK SURG,NASHVILLE,TN 37240
[2] VANDERBILT UNIV,MED CTR,DEPT DERMATOL,NASHVILLE,TN 37240
[3] VANDERBILT UNIV,MED CTR,DEPT PLAST SURG,NASHVILLE,TN 37240
[4] VET AFFAIRS MED CTR,RES SERV,NASHVILLE,TN 37212
来源
关键词
metalloproteinase; squamous cell carcinoma; TIMP; tissue inhibitor of metalloproteinase;
D O I
10.1177/000348949710600402
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Matrix metalloproteinases (MMPs) are a family of proteolytic enzymes implicated in the invasion and metastasis of many cancers. In situ hybridization techniques were used to reveal sites of expression of collagenase (MMP-1), gelatinase 72 kd (MMP-2), gelatinase 92kd (MMP-9), and tissue inhibitor of metalloproteinase-1 (TIMP-1) in head and neck carcinomas (N=21). Both TIMP-1 and gelatinase 72 kd were expressed in nearly all tumors, whereas the expression of collagenase and gelatinase 92 kd showed variability. Tumor-associated expression of MMPs was strongest in stromal cells near advancing margins. No differences in expression levels were detected between primary and metastatic sites. This paper reviews the literature and discusses the significance and possible implications of MMPs in head and neck squamous cell carcinoma.
引用
收藏
页码:271 / 278
页数:8
相关论文
共 50 条
  • [41] Matrix metalloproteinases and tissue inhibitors of metalloproteinases in bronchial squamous preinvasive lesions
    Galateau-Salle, FB
    Luna, RE
    Horiba, K
    Sheppard, MN
    Hayashi, T
    Fleming, MV
    Colby, TV
    Bennett, W
    Harris, CC
    Stetler-Stevenson, WG
    Liotta, L
    Ferrans, VJ
    Travis, WD
    HUMAN PATHOLOGY, 2000, 31 (03) : 296 - 305
  • [42] Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in malignant lymphoma
    Lee, AW
    Lee, AH
    Lee, KY
    Kang, CS
    Shim, SI
    Kim, BK
    MODERN PATHOLOGY, 2002, 15 (01) : 250A - 250A
  • [43] The expression and clinical significance of matrix metalloproteinase 7 and tissue inhibitor of matrix metalloproteinases 2 in clear cell renal cell carcinoma
    Lu, Hongsheng
    Yang, Zhaohui
    Zhang, Hui
    Gan, Meifu
    Zhou, Tao
    Wang, Siling
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 5 (03) : 890 - 896
  • [44] MATRIX METALLOPROTEINASES AND TISSUE INHIBITOR OF METALLOPROTEINASES - A REVIEW OF THEIR ROLE IN TUMORIGENESIS AND TISSUE INVASION
    KHOKHA, R
    DENHARDT, DT
    INVASION & METASTASIS, 1989, 9 (06): : 391 - 405
  • [45] Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in malignant lymphoma
    Lee, AW
    Lee, AH
    Lee, KY
    Kang, CS
    Shim, SI
    Kim, BK
    LABORATORY INVESTIGATION, 2002, 82 (01) : 250A - 250A
  • [46] Tissue inhibitors of matrix metalloproteinases in squamous cell carcinomas of the hypopharynx
    Heissenberg, MC
    Goeroegh, T
    Lippert, BM
    Werner, JA
    HEAD AND NECK CANCER - ADVANCES IN BASIC RESEARCH, 1996, 1114 : 475 - 480
  • [47] Expression of matrix metalloproteinases and their tissue inhibitor during viral encephalitis
    Zhou, JH
    Marten, NW
    Bergmann, CC
    Macklin, WB
    Hinton, DR
    Stohlman, SA
    JOURNAL OF VIROLOGY, 2005, 79 (08) : 4764 - 4773
  • [48] MATRIX METALLOPROTEINASES AND TISSUE INHIBITOR OF MATRIX METALLOPROTEINASES EXPRESSION BY TUBULAR EPITHELIA AND INTERSTITIAL FIBROBLASTS IN THE NORMAL KIDNEY AND IN FIBROSIS
    NORMAN, JT
    GATTI, L
    WILSON, PD
    LEWIS, M
    EXPERIMENTAL NEPHROLOGY, 1995, 3 (02): : 88 - 89
  • [49] Matrix metalloproteinases (MMPs) in oral squamous cell carcinoma.
    Dabbous, MK
    Haney, L
    Winn, B
    Tipton, D
    JOURNAL OF DENTAL RESEARCH, 1998, 77 : 110 - 110
  • [50] Differential expression of matrix metalloproteinases and the tissue inhibitor in human milk
    Cheung, PY
    Sawicki, G
    Gross, S
    Van Aerde, J
    Radomski, M
    PROCEEDINGS OF THE WESTERN PHARMACOLOGY SOCIETY, 2001, 44 : 97 - 98